As auditors for the pharmaceutical industry, we have the opportunity to visit the most wonderful places as well as the most interesting companies. We are lucky enough to conduct audits all over the world. Apart from visiting some exemplary companies, we sometimes encounter things we would rather not see. In these last few weeks of 2018, we are counting down the
As auditors for the pharmaceutical industry, we have the opportunity to visit the most wonderful places as well as the most interesting companies. We are lucky enough to conduct audits all over the world. Apart from visiting some exemplary companies, we sometimes encounter things we would rather not see. In these last few weeks of 2018, we are counting down the
As auditors for the pharmaceutical industry, we have the opportunity to visit the most wonderful places as well as the most interesting companies. We are lucky enough to conduct audits all over the world. Apart from visiting some exemplary companies, we sometimes encounter things we would rather not see. In these last few weeks of 2018, we are counting down the
As auditors for the pharmaceutical industry, we have the opportunity to visit the most wonderful places as well as the most interesting companies. We are lucky enough to conduct audits all over the world. Apart from visiting some exemplary companies, we sometimes encounter things we would rather not see. In these last few weeks of 2018, we are counting down the
On 21 and 22 November 2018, De Jong Pharma Consult completed the training for Responsible Person for the Good Distribution Practices for medicinal products for human use. This intensive course, provided by PCS is one of the few courses recognized by the Dutch Health Authority and therefore required for everyone that want to be registered as a Responsible Person.
Last month we saw why it was a good idea to outsource your supplier audits to professional auditors. We concluded it was both cheaper and faster and also creates more flexibility, consistency and objectivity. While performing (your) supplier audits, at least five levels of outsourcing can be distinguished. Each of these levels brings its own benefits.
It’s October 2018 and a lot of people now realize they will not be able to finalize their supplier audit program for this year. One of the main reasons for this is that supplier auditors who are employed by a company often have this task as part of another job.
As a pharmaceutical company or as a supplier to pharmaceutical companies, your internal audit program is essential in ensuring your compliance status. You know the program is always subject of scrutiny during health authority inspections and customer audits.
Patient safety of medication starts with safe ingredients. The news of August 3rd 2018 was that the UMC hospital in Amsterdam was asked (ordered) by the Dutch Health Authority to stop administering the in-house prepared drug for CTX (a metabolic disease) (Dutch newspaper article: https://www.telegraaf.nl/nieuws/2388301/amsterdam-umc-roept-medicijn-stofwisselingsziekte-terug)